Shopping Cart
- Remove All
- Your shopping cart is currently empty
Yonkenafil (Tunodafil), a novel phosphodiesterase 5 (PDE5) inhibitor, effectively reduces cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area, potentially enhancing cognitive function through neurogenesis modulation and offering therapeutic effects on Alzheimer's disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,140 | 8-10 weeks | |
50 mg | $1,490 | 8-10 weeks | |
100 mg | $2,360 | 8-10 weeks |
Description | Yonkenafil (Tunodafil), a novel phosphodiesterase 5 (PDE5) inhibitor, effectively reduces cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area, potentially enhancing cognitive function through neurogenesis modulation and offering therapeutic effects on Alzheimer's disease. |
Alias | Tunodafil |
Molecular Weight | 487.61 |
Formula | C24H33N5O4S |
Cas No. | 804518-63-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.